AMBER ADAMS: Open Payments
NPI 1053791616 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,386 in 106 payments from 26 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $2,386
Food & beverage: $2,371Education: $15
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 17 | $363 |
| TG Therapeutics, Inc. | 11 | $280 |
| Alexion Pharmaceuticals, Inc. | 6 | $185 |
| Amgen Inc. | 9 | $167 |
| C2N Diagnostics, LLC | 6 | $146 |
| ARGENX US, INC. | 6 | $125 |
| SK Life Science, Inc. | 5 | $122 |
| Biogen, Inc. | 5 | $122 |
| PFIZER INC. | 6 | $119 |
| Neurelis, Inc. | 5 | $90 |
Products named: BRIUMVI, Rystiggo, ULTOMIRIS, UPLIZNA, PRECIVITYAD2, VYVGART HYTRULO, NURTEC ODT, VUMERITY.
Industry payments across TN — which companies pay providers there.
